Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 241 AL 255

Alzheimer's Disease: Advances in Drug Development

Piton M, Hirtz C, Desmetz C, Milhau J, Lajoix AD, Bennys K, Lehmann S, Gabelle A.

J Alzheimers Dis. 2018;65(1):3-13. doi: 10.3233/JAD-180145.

Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?

Raikwar SP, Thangavel R, Dubova I, Ahmed ME, Selvakumar PG, Kempuraj D, Zaheer S, Iyer S, Zaheer A.

J Alzheimers Dis. 2018;65(2):321-344. doi: 10.3233/JAD-180422.

Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Cheng YC, Huang YC, Liu HC.

Dement Geriatr Cogn Disord. 2018;45(5-6):335-352. doi: 10.1159/000490175. Epub 2018 Jul 24.

Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer's disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients

Blanco-Silvente L, Capellà D, Garre-Olmo J, Vilalta-Franch J, Castells X.

BMC Geriatr. 2018 Jul 24;18(1):168. doi: 10.1186/s12877-018-0857-5.

Natural product-based multitargeted ligands for Alzheimer's disease treatment?

Tzvetkov NT, Atanasov AG.

Future Med Chem. 2018 Aug;10(15):1745-1748. doi: 10.4155/fmc-2018-0146. Epub 2018 Jul 25.

A review of clinical treatment considerations of donepezil in severe Alzheimer's disease

Adlimoghaddam A, Neuendorff M, Roy B, Albensi BC.

CNS Neurosci Ther. 2018 Oct;24(10):876-888. doi: 10.1111/cns.13035. Epub 2018 Jul 29.

Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer's disease dispensed by the Brazilian public health system - 2008 to 2014: a nation-wide analysis

Moraes FS, Souza MLC, Lucchetti G, Lucchetti ALG.

Arq Neuropsiquiatr. 2018 Jul;76(7):444-451. doi: 10.1590/0004-282X20180064.

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain

Hey JA, Kocis P, Hort J, Abushakra S, Power A, Vyhnálek M, Yu JY, Tolar M.

CNS Drugs. 2018 Sep;32(9):849-861. doi: 10.1007/s40263-018-0554-0.

A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease

Ajith TA.

Curr Clin Pharmacol. 2018;13(4):252-260. doi: 10.2174/1574884713666180807145648.

Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study

Colombo D, Caltagirone C, Padovani A, Sorbi S, Spalletta G, Simoni L, Ori A, Zagni E.

J Womens Health (Larchmt). 2018 Nov;27(11):1368-1377. doi: 10.1089/jwh.2017.6420. Epub 2018 Sep 8.

Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis

Duan Y, Lu L, Chen J, Wu C, Liang J, Zheng Y, Wu J, Rong P, Tang C.

BMC Geriatr. 2018 Aug 7;18(1):175. doi: 10.1186/s12877-018-0864-6.

Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives

de Castro AA, da Cunha EFF, Pereira AF, Soares FV, Leal DHS, Kuca K, Ramalho TC.

Curr Alzheimer Res. 2018;15(12):1161-1178. doi: 10.2174/1567205015666180813150703.

Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease

Tandon A, Singh SJ, Chaturvedi RK.

Biomed Res Int. 2018 Jul 12;2018:1483791. doi: 10.1155/2018/1483791. eCollection 2018.

Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study

Salloway S, Marshall GA, Lu M, Brashear HR.

Curr Alzheimer Res. 2018;15(13):1231-1243. doi: 10.2174/1567205015666180821114813.

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study

Timmers M, Streffer JR, Russu A, Tominaga Y, Shimizu H, Shiraishi A, Tatikola K, Smekens P, Börjesson-Hanson A, Andreasen N, Matias-Guiu J, Baquero M, Boada M, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.

Alzheimers Res Ther. 2018 Aug 23;10(1):85. doi: 10.1186/s13195-018-0415-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias